Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
Targeting CD38 with Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 2, 2024
An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-23)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 2, 2024
Phase II Study of Suratadenoturev (OBP-301) in Combination with Pembrolizumab in Immunotherapy Refractory Esophagogastric Adenocarcinoma
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 2, 2024
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 17, 2024
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk TIA (LIBREXIA-STROKE)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 17, 2024
A Multicentre, Phase II, Open-label Study to Evaluate the Efficacy of Acalabrutinib in Combination with Venetoclax and Rituximab in Participants with Treatment Naïve Mantle Cell Lymphoma (TrAVeRse)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 23, 2024
A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of KB707 in Subjects with Locally Advanced or Metastatic Solid Tumor Malignancies
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 23, 2024
A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients with Resectable Brain Metastases
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 23, 2024
Assessment of Placental Perfusion and Oxygenation Using Novel MRI Approaches
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 7, 2024
Technical Development for Fetal and Neonatal MRI
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 7, 2024
« first
‹ previous
…
17
18
19
20
21
(current)
22
23
24
25
…
next ›
last »